AI-powered Schistoscope could revolutionize diagnosis of parasitic disease

NewsGuard 100/100 Score

Schistosomiasis, a parasitic disease affecting millions worldwide, poses a significant public health and economic burden, particularly in impoverished regions.

To combat this disease and achieve World Health Organization (WHO) targets for control and elimination, accurate and accessible diagnostic tools are essential. Currently, microscopy is the standard for diagnosing schistosomiasis, but it is time-consuming, operator-dependent, and requires specialized expertise, making it challenging for resource-limited areas.

To address these challenges, researchers developed the Schistoscope, an innovative optical tool equipped with an autofocusing and automated slide scanning system.

This device captures microscopy images of urine samples, enabling efficient detection of Schistosoma haematobium eggs, a common cause of urogenital schistosomiasis. In a study published in the Journal of Medical Imaging, the researchers aimed to create a robust dataset and develop a two-stage diagnostic framework using deep learning to accurately identify and count S. haematobium (SH) eggs in field settings.

First, the researchers created an SH dataset consisting of 12,051 images of urine samples collected in a rural area in central Nigeria and captured using the Schistoscope device. They manually annotated the images, marking the eggs and differentiating them from artifacts such as crystals, glass debris, air bubbles, and fibers, which can hinder accurate diagnosis.

The proposed two-stage diagnostic framework consists of a DeepLabv3 with a MobilenetV3 backbone deep convolutional neural network, trained using transfer learning on the SH dataset. In the first stage, the framework performs semantic segmentation to identify candidate SH eggs in the captured images. The second stage refines the segmentation by fitting overlapping ellipses, effectively separating boundaries of clustered eggs, leading to more accurate egg counts.

To demonstrate the field applicability of the proposed framework, the researchers implemented it on an edge AI system (Raspberry Pi + Coral USB accelerator) and tested it on 65 clinical urine samples obtained in a field setting in Nigeria. The results showed high sensitivity, specificity, and precision (percentages: 93.75, 93.94, and 93.75, respectively), with the automated egg count closely correlated to the manual count by an expert microscopist.

This SH dataset serves as a valuable resource for training and evaluating the diagnostic framework, providing a diverse set of images with varying degrees of difficulty due to artifacts.

By automating the egg detection process, the Schistoscope and the proposed diagnostic framework offer a promising solution for the rapid and accurate diagnosis of urogenital schistosomiasis, particularly in low-resource settings. Future studies will further validate the framework's performance and compare it with other diagnostic methods, such as schistosome circulating antigen detection and DNA-based assays, to establish its role in schistosomiasis monitoring and control."

Jan Carel Diehl, Study Corresponding Author and Professor, Department of Sustainable Design Engineering, Delft University of Technology

Overall, this work represents a significant step towards improving diagnostics and combatting schistosomiasis, a disease that disproportionately affects vulnerable populations in endemic regions.

Source:
Journal reference:

Oyibo, P., et al. (2023) Two-stage automated diagnosis framework for urogenital schistosomiasis in microscopy images from low-resource settings. Journal of Medical Imaging. doi.org/10.1117/1.JMI.10.4.044005.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New blood test shows promise in early detection of ovarian cancer